Finasteride Use and Risk of Male Breast Cancer: A Case-Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden

    March 2019 in “ Cancer Epidemiology, Biomarkers & Prevention ”
    Thora Majlund Kjærulff, Annette Kjær Ersbøll, A. Green … Lau Caspar Thygesen
    Studysummary This study found no evidence that finasteride use is associated with an increased risk of male breast cancer.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on cebp.aacrjournals.org →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Finasteride Treatment and Male Breast Cancer: A Register-Based Cohort Study in Four Nordic Countries Cancer Medicine · 2017
    2. Androgenetic Alopecia: A Review Endocrine · 2017
    3. Patterns of Finasteride Use in the Male Populations of Four Nordic Countries: A Cross-National Drug Utilization Study Scandinavian journal of urology · 2016
    4. Long-Term Use of 5α-Reductase Inhibitors and the Risk of Male Breast Cancer Cancer Causes & Control · 2014
    5. Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride The Journal of Urology · 2013